Last: | $0.88 |
---|---|
Change Percent: | 4.38% |
Open: | $0.8415 |
Close: | $0.88 |
High: | $0.9 |
Low: | $0.826 |
Volume: | 535,217 |
Last Trade Date Time: | 05/08/2020 04:47:28 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.88 | $0.8415 | $0.88 | $0.9 | $0.826 | 535,217 | 05-08-2020 |
$0.8431 | $0.85 | $0.8431 | $0.85 | $0.8201 | 614,178 | 05-07-2020 |
$0.8401 | $0.91 | $0.8401 | $0.91 | $0.8001 | 1,091,947 | 05-06-2020 |
$0.89 | $0.9345 | $0.89 | $0.95 | $0.87 | 555,027 | 05-05-2020 |
$0.91 | $0.86 | $0.91 | $0.91 | $0.8001 | 1,268,713 | 05-04-2020 |
$0.9001 | $1.01 | $0.9001 | $1.01 | $0.85 | 1,060,392 | 05-01-2020 |
$1 | $1.02 | $1 | $1.03 | $0.95 | 1,151,640 | 04-30-2020 |
$1.04 | $0.9135 | $1.04 | $1.05 | $0.8701 | 2,729,578 | 04-29-2020 |
$0.86 | $0.89 | $0.86 | $0.91 | $0.83 | 1,756,190 | 04-28-2020 |
$0.89 | $0.995 | $0.89 | $0.995 | $0.8716 | 816,041 | 04-27-2020 |
$0.95 | $0.9825 | $0.95 | $1.02 | $0.9175 | 760,863 | 04-24-2020 |
$1.03 | $1.05 | $1.03 | $1.05 | $1 | 571,821 | 04-23-2020 |
$1.02 | $1.11 | $1.02 | $1.11 | $1.02 | 462,016 | 04-22-2020 |
$1.03 | $1.11 | $1.03 | $1.11 | $1.01 | 525,512 | 04-21-2020 |
$1.12 | $1.17 | $1.12 | $1.22 | $1.1 | 583,874 | 04-20-2020 |
$1.16 | $1.19 | $1.16 | $1.2511 | $1.16 | 549,435 | 04-17-2020 |
$1.15 | $1.25 | $1.15 | $1.27 | $1.12 | 867,612 | 04-16-2020 |
$1.24 | $1.24 | $1.24 | $1.25 | $1.16 | 548,790 | 04-15-2020 |
$1.22 | $1.21 | $1.22 | $1.28 | $1.1601 | 604,022 | 04-14-2020 |
$1.15 | $1.26 | $1.15 | $1.3 | $1.07 | 961,757 | 04-13-2020 |
News, Short Squeeze, Breakout and More Instantly...
Avianca Holdings S.A. American Depositary Shares (Each representing 8 preferred Shares) Company Name:
AVH Stock Symbol:
NYSE Market:
VALENCIA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its first quarter 2024 financia...
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its expected commercial revenue for th...
Tier-1 Customer to Use High-Performance Akoustis XBAW ® Filters in 4X4 MU-MIMO Enterprise Router Platform Company Has Received Volume Orders to Facilitate Production Ramp in the Second Half of Calendar Year 2024 Charlotte, N.C., April 08, 2024 (GLOBE NEWSWIRE) -- Akoustis...